Ethnopharmacologic Search For Psychoactive Drugs

Symposium Livestream

23 - 26 May 2022

Livestream Symposium23-26 May 202223-26 MayATTEND
26 Nov 2021

The Guardian: Psychedelics can change humanity for the better

"We envision a day when psychedelics will be more than a last-ditch treatment: they will be a catalyst for mass mental health."


- Rick Doblin (Multidisciplinary Association for Psychedelic Studies (MAPS)) for The Guardian.


MAPS Founder Rick Doblin, Ph.D., explores how advancing scientific understanding of psychedelic therapies offers hope for achieving mass mental health. Doblin illustrates the statistically significant results of the first MAPS-sponsored Phase 3 clinical trial of MDMA-assisted therapy for PTSD, highlights recent systematic reviews of research into treating medical conditions with psychedelic therapy, and explains how legalization and regulation are less dangerous than continuing the War on Drugs.


"Four separate systematic reviews have been published this year highlighting the potential of psychedelic-assisted therapies for those conditions and more: end of life care, brain injury, neurodegenerative disorders, mood disorders, smoking cessation and addiction or dependence. Dozens of studies make a compelling case for rapid expansion of research into psychedelic-assisted therapies for serious mental health conditions.


Evidence indicates that psychedelic use is associated with pro-social, personal growth benefits including increased nature relatedness, potentiating conflict resolution and sustaining compassion among first responders. Indigenous communities around the globe have used psychedelics in spiritual ceremony and healing for millennia.


Conversely, the well-documented devastation of the war on drugs has been responsible for untold trauma. But is the legalization and regulation of all substances – reversing the course on the war on drugs – too dangerous? Simply: No. It’s more dangerous not to."



News and event updates from the McKenna Academy.